JPH0236178B2 - - Google Patents
Info
- Publication number
- JPH0236178B2 JPH0236178B2 JP57170482A JP17048282A JPH0236178B2 JP H0236178 B2 JPH0236178 B2 JP H0236178B2 JP 57170482 A JP57170482 A JP 57170482A JP 17048282 A JP17048282 A JP 17048282A JP H0236178 B2 JPH0236178 B2 JP H0236178B2
- Authority
- JP
- Japan
- Prior art keywords
- creatinine
- measuring
- cre
- sample
- main line
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 52
- 229940109239 creatinine Drugs 0.000 claims description 27
- 238000005259 measurement Methods 0.000 claims description 18
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108010060059 Sarcosine Oxidase Proteins 0.000 claims description 4
- 102000008118 Sarcosine oxidase Human genes 0.000 claims description 4
- 108010077078 Creatinase Proteins 0.000 claims description 3
- 108010066906 Creatininase Proteins 0.000 claims description 3
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 239000010839 body fluid Substances 0.000 claims description 3
- 108090000604 Hydrolases Proteins 0.000 claims description 2
- 102000004157 Hydrolases Human genes 0.000 claims description 2
- 238000004364 calculation method Methods 0.000 claims description 2
- 238000012937 correction Methods 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- -1 creatinine amidine Chemical class 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 17
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000007853 buffer solution Substances 0.000 description 10
- 108010093096 Immobilized Enzymes Proteins 0.000 description 7
- 229960003624 creatine Drugs 0.000 description 7
- 239000006046 creatine Substances 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000011197 physicochemical method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
【発明の詳細な説明】
本発明は、血液等の体液中に含まれる化学成分
のうち、クレアチニン(CRE)を測定し得る装
置に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a device capable of measuring creatinine (CRE) among chemical components contained in body fluids such as blood.
臨床検査の有用性については最近益々喧騒され
るところであり、例えば人工腎による透析療法を
受ける患者にとつては、血中のCRE量を測定す
ることが極めて重要である。従来CREの測定は
用手法に基づいてなされていたが、最近自動分析
機器の開発が進み、既に幾つかは商品化されてい
る。しかし商品化されたものは、装置自体が高価
であるだけでなく、試薬或は溶液状酵素を利用す
るものであるからランニングコストが高くつくと
いう欠点があつた。又人工腎による透析療法中の
モニタリングやベツドサイド乃至採血直後の測定
を行なう場合、全血測定を必要とするが、全血測
定では従来の比色法が利用できないので、固定化
酵素ビーズをカラムに充填して測定することもあ
る。しかしこの方式では全血の為に目詰りを起こ
し易いという難点が指摘される。 Recently, the usefulness of clinical tests has been increasingly talked about, and for example, for patients undergoing dialysis therapy using an artificial kidney, it is extremely important to measure the amount of CRE in the blood. Conventionally, CRE measurements have been carried out using manual methods, but the development of automatic analytical instruments has progressed recently, and some have already been commercialized. However, the commercialized devices have the disadvantage that not only the devices themselves are expensive, but also the running costs are high because they use reagents or solution enzymes. In addition, when monitoring during dialysis therapy using an artificial kidney or performing measurements from the bedside or immediately after blood collection, whole blood measurements are required, but conventional colorimetric methods cannot be used for whole blood measurements, so immobilized enzyme beads are attached to the column. Sometimes it is filled and measured. However, it has been pointed out that this method has the disadvantage that it is prone to clogging due to the use of whole blood.
本発明はこの様な事情に着目してなされたもの
であつて、全血を被検液としても測定が可能で、
CRE量を低ランニングコストで且つ速やかに測
定できる様な測定装置を提供しようとするもので
ある。 The present invention has been made with attention to these circumstances, and it is possible to perform measurements using whole blood as a test liquid.
The purpose of this invention is to provide a measuring device that can quickly measure the amount of CRE at low running costs.
即ち本発明は夫々被検液を流すべき主ラインと
補償ラインを並列的に形成すると共に、主ライン
には固定化酵素膜付きのクレアチニン測定部を、
又補償ラインには固定化酵素膜付きのクレアチン
測定部を夫々設け、且つ各測定部を修正演算部に
連結してなる点に要旨が存在する。尚固定化酵素
膜としては、特開昭52−55691や同54−102193等
に記載されたものが利用できる。 That is, in the present invention, a main line and a compensation line are formed in parallel through which test liquids are to flow, and a creatinine measuring section with an immobilized enzyme membrane is installed in the main line.
Moreover, the gist lies in that each compensation line is provided with a creatine measuring section with an immobilized enzyme membrane, and each measuring section is connected to a correction calculation section. As the immobilized enzyme membrane, those described in JP-A-52-55691 and JP-A-54-102193 can be used.
CREの測定に当つては、酵素としてクレアチ
ニンアミドヒドロラーゼを用い、生成したクレア
チンを今度はクレアチンアミジノヒドロラーゼの
作用によつてザルコシンと尿素に分解し、更にザ
ルコシンをザルコシンオキシダーゼによつてグリ
シン、ホルムアルデヒド及び過酸化水素に分解す
る。そしてこの過酸化水素を、アンペロメトリー
型の過酸化水素電極によつて測定する。 In measuring CRE, creatinine amidohydrolase is used as the enzyme.The generated creatine is then decomposed into sarcosine and urea by the action of creatine amidinohydrolase, and the sarcosine is further decomposed into glycine, formaldehyde and urea by the action of sarcosine oxidase. Decomposes into hydrogen peroxide. This hydrogen peroxide is then measured using an amperometric hydrogen peroxide electrode.
本発明においては、クレアチニンアミドヒドロ
ラーゼ、クレアチンアミジノヒドロラーゼ、ザル
コシンオキシダーゼ(以下酵素という)を適当な
フイルム又はシートに夫々担持させてなる固定化
酵素膜を利用して上記酵素と基質の反応を行なわ
せる様な構成を採用している。即ち酵素は固体状
で保持されるので、失活することがない限り継続
して使うことができるという利点があり、基質が
上記の固定化酵素膜に接触すると該基質に特異な
酵素反応が生起し一般に種々の分解生成物が発生
する。この分解生成物は、物理化学的手法、化学
的手法及び生化学的手法から選ばれる任意の方法
で測定すればよいが、クレアチニンアミドヒドロ
ラーゼ等によるCREの分解産物である過酸化水
素については、前述のアンペロメトリー型の過酸
化水素電極を利用する方法が推奨される。 In the present invention, the reaction between the enzyme and the substrate is carried out using an immobilized enzyme membrane in which creatinine amidohydrolase, creatine amidinohydrolase, and sarcosine oxidase (hereinafter referred to as enzymes) are each supported on a suitable film or sheet. Various configurations are adopted. In other words, since the enzyme is retained in a solid state, it has the advantage of being able to be used continuously as long as it does not become inactivated, and when the substrate comes into contact with the above-mentioned immobilized enzyme membrane, an enzyme reaction specific to the substrate occurs. However, various decomposition products are generally generated. This decomposition product may be measured by any method selected from physicochemical methods, chemical methods, and biochemical methods, but hydrogen peroxide, which is a decomposition product of CRE by creatinine amide hydrolase, etc., can be measured as described above. A method using an amperometric hydrogen peroxide electrode is recommended.
尚本発明に係るアンペロメトリー型の過酸化水
素電極は、電極の表面を覆つた酵素薄膜に、静止
状態又は流動状態で基質が接触し、生成した過酸
化水素の濃度を測定して基質(この場合CRE)
の濃度を求める。静止状態で接触させ、例えば
0.5秒毎に10秒間ずつ測定することを数回繰り返
し、最小2乗法に基づいて直線回帰の係数を演算
して濃度を求める方法はレート法と称され、他方
流動状態で接触させて酵素反応を行なわせその結
果を連続的に測定して濃度を求める方法はフロー
スルー法と称されるが、これら手法のいずれを採
用するかは本発明を実施する者の自由である。 In the amperometric type hydrogen peroxide electrode according to the present invention, a substrate is brought into contact with an enzyme thin film covering the surface of the electrode in a static state or a flowing state, and the concentration of the generated hydrogen peroxide is measured. In this case CRE)
Find the concentration of Contact in a stationary state, e.g.
The method of repeating measurements for 10 seconds every 0.5 seconds several times and calculating the linear regression coefficient based on the least squares method to determine the concentration is called the rate method. A method for determining the concentration by continuously measuring the results is called a flow-through method, and the person implementing the present invention is free to choose which of these methods to adopt.
次に本発明の代表例に従つて分析装置の構成及
び作用効果を説明する。 Next, the configuration and effects of the analyzer will be explained according to a representative example of the present invention.
第1,2図は本発明で用いるサンプル定量化6
方弁V1及びV2の作動説明図、第3図は装置全体
の概念図である。尚第3図において6方弁V1に
接続される上側のラインL1は主ライン、下側の
ラインL2は補償ラインを示し、これらのライン
を設けた理由は次の通りである。即ち血中には無
視し得ない量のクレアチンが存在しており、
CREの測定における過酸化水素の定量に際して
上記のクレアチンも一緒に検知されてしまう。従
つて補償ラインL2においてクレアチンのみを測
定し、主ラインL1における測定値からこの値を
差し引いて正しいCREを求める。 Figures 1 and 2 show sample quantification 6 used in the present invention.
An explanatory diagram of the operation of the direction valves V1 and V2 , and FIG. 3 is a conceptual diagram of the entire device. In FIG. 3, the upper line L1 connected to the six-way valve V1 is the main line, and the lower line L2 is the compensation line.The reason for providing these lines is as follows. In other words, there is a non-negligible amount of creatine in the blood.
When quantifying hydrogen peroxide in the measurement of CRE, the above-mentioned creatine is also detected. Therefore, only creatine is measured on the compensation line L2 , and this value is subtracted from the measured value on the main line L1 to determine the correct CRE.
<洗浄工程>
第2図に従つて洗浄液、好ましくは緩衝液が矢
印A′1に沿う様に導入され、6方弁V1,V2を夫々
−の順に流れさせ、矢印A′2に沿つて放出さ
せておく。尚この流れはポンプP3の吸入によつ
て行なう。他方ポンプP1,P2を作動させて貯留
槽9内の緩衝液を吸入し、第2図の矢印B′1→B′2
及びC′1→C′2に沿つて流し、測定装置の主ライン
L1及び補償ラインL2内に緩衝液を通しておく。
尚6方弁V1及びV2内における緩衝液の流れは
→→→である。<Washing step> According to FIG. 2, a washing solution, preferably a buffer solution, is introduced along the arrow A' 1 , and is caused to flow through the six-way valves V 1 and V 2 in the order of -, respectively. Let it release. Note that this flow is performed by suction from pump P3 . On the other hand, pumps P 1 and P 2 are operated to suck the buffer solution in the storage tank 9, and the arrow B' 1 →B' 2 in FIG.
and flow along C′ 1 →C′ 2 , the main line of the measuring device
A buffer solution is passed through L1 and compensation line L2 .
The flow of the buffer solution in the six-way valves V1 and V2 is →→→.
<サンプルの注入>
洗浄が十分に行なわれると、ポンプP3を停止
すると共に6方弁V1,V2を第1図の様に切り換
える。ポンプP1,P2は引続き作動させており、
緩衝液は6方弁を通つてB1→B2及びC1→C2に流
しておく。そして矢印A1に沿つてサンプルの注
入を開始し、サンプルは各6方弁を→→→
の順に流す。サンプルは血液であるからその先
端がホトセンサーPs位置に到達した段階でホト
センサーPsによつて検知される。この段階で回
路→→→内はサンプルで充満されたこと
になり、一定量のサンプルが定量保持される。尚
血液以外の体液を対象とする時はホトセンサーを
省略し、ポンプP1,P2をパルスモータとし、パ
ルスを検出しながら一定数に到達したことをもつ
てサンプルの到達を推定しても良い。尚以下述べ
るホトセンサーについても全て同様に考えること
ができる。<Sample injection> When washing has been sufficiently performed, pump P3 is stopped and six-way valves V1 and V2 are switched as shown in FIG. Pumps P 1 and P 2 continue to operate.
The buffer solution is allowed to flow from B 1 to B 2 and from C 1 to C 2 through a six-way valve. Then, start injecting the sample along arrow A 1 , and the sample enters each 6-way valve →→→
Flow in this order. Since the sample is blood, it is detected by the photosensor Ps when its tip reaches the photosensor Ps position. At this stage, the inside of the circuit →→→ is filled with sample, and a fixed amount of sample is retained. When targeting body fluids other than blood, it is also possible to omit the photo sensor and use pulse motors for pumps P 1 and P 2 , and estimate the arrival of the sample by detecting pulses and reaching a certain number of pulses. good. Note that all the photosensors described below can be considered in the same way.
<測定開始>
6方弁V1,V2を切り換えて再び第2図の状態
に戻し、矢印B′1及びC′1に沿つて導入されている
緩衝液により上記定量サンプルを矢印B′2及びC′2
方向に追い出すと共にポンプP3を停止する。ポ
ンプP3の停止は、ホトセンサーPsによる検知と
同時に行なつてもよいが、適当なタイマーを利用
し、検知後一定時間を置いてから停止させる方法
であれば、回路→→→内の緩衝液をサン
プルによつて完全に放出し且つ置換する為の時間
的余裕が得られるので、測定精度の安定化という
点で極めて好都合である。<Measurement start> Switch the six-way valves V 1 and V 2 to return to the state shown in Figure 2, and transfer the quantitative sample to the arrow B' 2 using the buffer solution introduced along the arrows B' 1 and C ' 1 . and C′ 2
direction and stop pump P3 . Pump P 3 may be stopped at the same time as the detection by photo sensor Ps, but if a suitable timer is used to stop pump P 3 after a certain period of time after detection, the buffer in the circuit This is extremely advantageous in terms of stabilizing measurement accuracy, as it provides time for the liquid to be completely discharged and replaced by the sample.
<ミキシング>
以後の具体的測定を行なうに当つては、サンプ
ルと緩衝液を完全に混合して至適PH等を整えてお
く必要があり、ミキシングコイルM1,M2に送ら
れる。尚第3図の鎖線領域内は温度調整域であ
り、温度指示調整器TICによつて酵素反応に好適
な温度を保持する様に調整されている。従つてミ
キシングコイルM1,M2内のサンプルは緩衝液に
よる希釈を受けると同時に一定温度迄昇温され
る。尚ポンプP1,P2は一点鎖線で示す様に連動
されており、主ラインL1及び補償ラインL2を流
れるサンプルの流速は、マイクロコンピユーター
MC及び駆動インターフエースMIによつて同一
の且つ任意の速度が与えられる様に調整される。<Mixing> For subsequent specific measurements, it is necessary to completely mix the sample and buffer solution to adjust the optimum pH, etc., and the sample and buffer solution are sent to mixing coils M 1 and M 2 . The area within the chain line area in FIG. 3 is the temperature adjustment area, which is adjusted by the temperature indicating regulator TIC to maintain a temperature suitable for the enzyme reaction. Therefore, the samples in the mixing coils M 1 and M 2 are diluted with the buffer solution and at the same time are heated to a certain temperature. The pumps P 1 and P 2 are linked as shown by the dashed line, and the flow rate of the sample flowing through the main line L 1 and the compensation line L 2 is determined by the microcomputer.
Adjustment is made so that the same and arbitrary speed is given by the MC and the drive interface MI.
<CREの測定>
ミキシングコイルを出たサンプルと緩衝液の混
合物(以下被検液という)の先端がホトセンサー
Ps1及びPs2によつて検知されると、ポンプP1
及びP2が制御され、CRE測定にとつて最適の被
検液速度(通常1ml/min前後)に調整される。
そして被検液の流れ状態から推定される最高濃度
部分がCRE測定電極2及びクレアチン測定電極
5に到達するタイミングを見計つてポンプP1及
びP2を停止する。即ちここではレート法を採用
し、例えば0.5秒毎に10秒間ずつCRE濃度を測定
し、最小2乗法に従つて直線回帰の係数を演算す
る。尚クレアチンの測定を電極5で行う。そして
それらの結果を、アナログ・デジタル・コンバー
ターシステム(以下ADCシステム)7にインプ
ツトし、正しいCRE測定値を求める。<CRE measurement> The tip of the sample and buffer mixture (hereinafter referred to as the test solution) that exits the mixing coil is a photo sensor.
When detected by Ps1 and Ps2, pump P1
and P 2 are controlled and adjusted to the optimum test liquid velocity (usually around 1 ml/min) for CRE measurement.
Then, the pumps P 1 and P 2 are stopped at the timing when the highest concentration portion estimated from the flow state of the test liquid reaches the CRE measurement electrode 2 and the creatine measurement electrode 5. That is, the rate method is adopted here, and the CRE concentration is measured every 10 seconds, for example, every 0.5 seconds, and linear regression coefficients are calculated according to the least squares method. Note that creatine is measured using electrode 5. These results are then input to an analog-to-digital converter system (hereinafter referred to as ADC system) 7 to obtain correct CRE measurement values.
<洗浄再開>
CREの測定が終了すると6方弁V1,V2を切り
換えて第1図の状態とし、流速を高めて緩衝液を
主ラインL1及び補償ラインL2に送り込み被検液
を放出する。被検液の存在がなくなつたことはホ
トセンサーPs7及びPs8で検知し、洗浄工程の
終了を判断する。他方ポンプP3も再作動させ、
6方弁V1,V2内を洗浄し、次回のサンプル注入
に備える。<Resuming cleaning> When the CRE measurement is completed, switch the 6-way valves V 1 and V 2 to the state shown in Figure 1, increase the flow rate, and send the buffer solution to the main line L 1 and compensation line L 2 to remove the test solution. discharge. The absence of the test liquid is detected by the photosensors Ps7 and Ps8, and the end of the cleaning process is determined. On the other hand, pump P 3 is also restarted,
Clean the inside of the 6-way valves V 1 and V 2 to prepare for the next sample injection.
以上の測定例では、CREをレート法で測定し
たが、勿論フロースルー方式とすることも可能で
ある。 In the above measurement example, CRE was measured using the rate method, but of course it is also possible to use the flow-through method.
本発明の装置は上記の如く構成されているから
CREが連続的に測定され、しかも測定部には固
定化酵素膜を用いているから、装置の取り扱いが
容易であると共に、ランニングコストの低減を図
ることができる。尚本発明の測定装置には必要に
応じてNa、K、Clなどを電極法により測定する
装置を付加してもよい。 Since the device of the present invention is configured as described above,
Since CRE is measured continuously and an immobilized enzyme membrane is used in the measuring section, the device is easy to handle and running costs can be reduced. Note that the measuring device of the present invention may be provided with a device for measuring Na, K, Cl, etc. by an electrode method, if necessary.
第1,2図は定量化6方弁の作動説明図、第3
図は本発明装置の全体概念図である。
P……ポンプ、Ps……ホトセンサー、V……
サンプル定量化6方弁、L1……主ライン、L2…
…補償ライン。
Figures 1 and 2 are explanatory diagrams of the operation of the 6-way quantification valve, and Figure 3
The figure is an overall conceptual diagram of the device of the present invention. P...pump, Ps...photo sensor, V...
Sample quantification 6-way valve, L 1 ... Main line, L 2 ...
…compensation line.
Claims (1)
あつて、それぞれ被検液を流すべき主ラインと補
償ラインを並列的に形成すると共に、主ラインに
はクレアチニンアミドヒドロラーゼ、クレアチン
アミジノヒドロラーゼ、およびザルコシンオキシ
ダーゼの固定化酵素膜を配し生成したH2O2を測
定するクレアチニン測定部を、又補償ラインには
クレアチンアミジノヒドロラーゼ、ザルコシンオ
キシダーゼの固定化酸素膜を配し生成したH2O2
を測定するクレアチン測定部を夫々設け、且つ各
測定部を修正演算部に連結してなることを特徴と
するクレアチニン測定装置。 2 特許請求の範囲第1項において、測定部へ供
給する被検液の流速調整装置を配備したものであ
るクレアチニン測定装置。[Scope of Claims] 1. A measuring device for measuring creatinine in a body fluid, in which a main line and a compensation line through which a test liquid flows are formed in parallel, and the main line contains creatinine amidohydrolase, creatinine amidine, A creatinine measurement part was arranged to measure the generated H 2 O 2 by placing an enzyme membrane with immobilized hydrolase and sarcosine oxidase, and an immobilized oxygen membrane with creatine amidinohydrolase and sarcosine oxidase was placed in the compensation line. H2O2 _
What is claimed is: 1. A creatinine measuring device comprising: creatinine measuring sections for measuring creatinine, and each measuring section is connected to a correction calculation section. 2. The creatinine measuring device according to claim 1, which is equipped with a flow rate adjusting device for the test liquid supplied to the measuring section.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57170482A JPS5873856A (en) | 1982-09-28 | 1982-09-28 | Creatinine measuring apparatus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57170482A JPS5873856A (en) | 1982-09-28 | 1982-09-28 | Creatinine measuring apparatus |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55160969A Division JPS5784345A (en) | 1980-11-15 | 1980-11-15 | 3-items analyzer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5873856A JPS5873856A (en) | 1983-05-04 |
| JPH0236178B2 true JPH0236178B2 (en) | 1990-08-15 |
Family
ID=15905764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57170482A Granted JPS5873856A (en) | 1982-09-28 | 1982-09-28 | Creatinine measuring apparatus |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5873856A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03263773A (en) * | 1990-03-13 | 1991-11-25 | Kokusai Electric Co Ltd | Pressure contact type connector |
-
1982
- 1982-09-28 JP JP57170482A patent/JPS5873856A/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03263773A (en) * | 1990-03-13 | 1991-11-25 | Kokusai Electric Co Ltd | Pressure contact type connector |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5873856A (en) | 1983-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2238548C2 (en) | Method for measuring concentration of analyzed substance (variants), measuring device for doing the same | |
| EP0614081B1 (en) | A method and a system for measuring the concentration of a substance in a fluid, and the use thereof | |
| US4490235A (en) | Electrochemical cell provided with selective electrodes and at least one chemical reactor, for indirect measurement of clinical-chemical parameters | |
| JP4554171B2 (en) | Analytical test cartridge and method | |
| Jenkins et al. | Manometric biosensor for on-line measurement of milk urea | |
| US5976465A (en) | Apparatus and method for the determination of substances in solution suspension or emulsion by differential pH measurement | |
| JPS6353502B2 (en) | ||
| JPH0236178B2 (en) | ||
| US20100319736A1 (en) | Sensing device | |
| CN114965845B (en) | Kjeldahl nitrogen determination instrument capable of eliminating error caused by long time interval in continuous detection | |
| JPH0375823B2 (en) | ||
| JPH08101212A (en) | Liquid sample continuous measuring device | |
| JPH0377460B2 (en) | ||
| JP2928588B2 (en) | Alcohol measurement method and measurement device | |
| US12455216B2 (en) | Sampling method | |
| JP3497806B2 (en) | Water quality monitoring device | |
| JPH1123580A (en) | Biochemical automatic analyzer | |
| JPH0134116Y2 (en) | ||
| JPH0564304B2 (en) | ||
| JPS5510523A (en) | Analyzer using enzyme | |
| JP2002048755A (en) | Liquid sample measuring method and measuring device | |
| JPH0543269B2 (en) | ||
| JPS588744B2 (en) | Ammonia nitrogen analysis method in water | |
| JPS6332137B2 (en) | ||
| JPH0526144B2 (en) |